Trials / Completed
CompletedNCT00067457
Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
A 12-Week, Randomized, Double-Blind, Placebo- Controlled Study of PRN BID and Fixed Dosing Regimens of Alosetron in Female Subjects With Severe Diarrhea-Predominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 700 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and effectiveness of as needed versus fixed dosing of an investigational medication for women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | alosetron |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2003-08-21
- Last updated
- 2015-04-16
Locations
191 sites across 2 countries: United States, Australia
Source: ClinicalTrials.gov record NCT00067457. Inclusion in this directory is not an endorsement.